Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2005

Open Access 01-12-2004 | Research article

Microcirculation abnormalities in patients with fibromyalgia – measured by capillary microscopy and laser fluxmetry

Authors: Susanne Morf, Beatrice Amann-Vesti, Adrian Forster, Ulrich K Franzeck, Renate Koppensteiner, Daniel Uebelhart, Haiko Sprott

Published in: Arthritis Research & Therapy | Issue 2/2005

Login to get access

Abstract

This unblinded preliminary case-control study was done to demonstrate functional and structural changes in the microcirculation of patients with primary fibromyalgia (FM). We studied 10 women (54.0 ± 3.7 years of age) with FM diagnosed in accordance with the classification criteria of the American College of Rheumatology, and controls in three groups (n = 10 in each group) – age-matched women who were healthy or who had rheumatoid arthritis or systemic scleroderma (SSc). All 40 subjects were tested within a 5-week period by the same investigators, using two noninvasive methods, laser fluxmetry and capillary microscopy. The FM patients were compared with the healthy controls (negative controls) and with rheumatoid arthritis patients and SSc patients (positive controls). FM patients had fewer capillaries in the nail fold (P < 0.001) and significantly more capillary dilatations (P < 0.05) and irregular formations (P < 0.01) than the healthy controls. Interestingly, the peripheral blood flow in FM patients was much less (P < 0.001) than in healthy controls but did not differ from that of SSc patients (P = 0.73). The data suggest that functional disturbances of microcirculation are present in FM patients and that morphological abnormalities may also influence their microcirculation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Schmidt KL, Ed: Checkliste Rheumatologie. 1991, Stuttgart: Georg Thieme, 303-305. Schmidt KL, Ed: Checkliste Rheumatologie. 1991, Stuttgart: Georg Thieme, 303-305.
2.
go back to reference Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 1988, 32: 21-26. 10.1016/0304-3959(88)90019-X.CrossRefPubMed Vaeroy H, Helle R, Forre O, Kass E, Terenius L: Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis. Pain. 1988, 32: 21-26. 10.1016/0304-3959(88)90019-X.CrossRefPubMed
3.
go back to reference Frodin T, Bengtsson A, Skogh M: Nail fold capillaroscopy findings in patients with primary fibromyalgia. Clin Rheumatol. 1988, 7: 384-388.CrossRefPubMed Frodin T, Bengtsson A, Skogh M: Nail fold capillaroscopy findings in patients with primary fibromyalgia. Clin Rheumatol. 1988, 7: 384-388.CrossRefPubMed
4.
go back to reference Jeschonneck M, Grohmann G, Hein G, Sprott H: Abnormal microcirculation and temperature in skin above tender point in patients with fibromyalgia. Rheumatology. 2000, 39: 917-921. 10.1093/rheumatology/39.8.917.CrossRefPubMed Jeschonneck M, Grohmann G, Hein G, Sprott H: Abnormal microcirculation and temperature in skin above tender point in patients with fibromyalgia. Rheumatology. 2000, 39: 917-921. 10.1093/rheumatology/39.8.917.CrossRefPubMed
5.
go back to reference Dabich L, Bookstein JJ, Zweifler A, Zarafonetis CJ: Digital arteries in patients with scleroderma: arteriographic and plethysmographic studies. Arch Intern Med. 1972, 130: 708-714. 10.1001/archinte.130.5.708.CrossRefPubMed Dabich L, Bookstein JJ, Zweifler A, Zarafonetis CJ: Digital arteries in patients with scleroderma: arteriographic and plethysmographic studies. Arch Intern Med. 1972, 130: 708-714. 10.1001/archinte.130.5.708.CrossRefPubMed
6.
go back to reference Brülisauer M, Bollinger A: Measurement of different human microvascular dimensions by combination of videomicroscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp. 1991, 10: 21-31.PubMed Brülisauer M, Bollinger A: Measurement of different human microvascular dimensions by combination of videomicroscopy with Na-fluorescein (NaF) and indocyanine green (ICG) in normals and patients with systemic sclerosis. Int J Microcirc Clin Exp. 1991, 10: 21-31.PubMed
7.
go back to reference Altomonte L, Zoli A, Galossi A, Mirone L, Tulli A, Martone FR, Morini P, Laraia P, Magaro M: Microvascular capillaroscopic abnormalities in rheumatoid arthritis patients. Clin Exp Rheumatol. 1995, 13: 83-86.PubMed Altomonte L, Zoli A, Galossi A, Mirone L, Tulli A, Martone FR, Morini P, Laraia P, Magaro M: Microvascular capillaroscopic abnormalities in rheumatoid arthritis patients. Clin Exp Rheumatol. 1995, 13: 83-86.PubMed
8.
go back to reference Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172.CrossRefPubMed Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P: The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990, 33: 160-172.CrossRefPubMed
9.
go back to reference Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, et al: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999, 26: 2159-2167.PubMed Medsger TA, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, Harris CA, Jablonska S, Jayson MI, Jimenez SA, et al: A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999, 26: 2159-2167.PubMed
10.
go back to reference Bollinger A, Jager K, Siegenthaler W: Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med. 1986, 146: 1541-1545. 10.1001/archinte.146.8.1541.CrossRefPubMed Bollinger A, Jager K, Siegenthaler W: Microangiopathy of progressive systemic sclerosis. Evaluation by dynamic fluorescence videomicroscopy. Arch Intern Med. 1986, 146: 1541-1545. 10.1001/archinte.146.8.1541.CrossRefPubMed
11.
go back to reference Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Junger M, Jung F, Lawall H: Standardisierung der Nagelfalz-Kapillarmikroskopie in der Routinediagnostik. VASA. 1997, 25: 5-10. Schmidt JA, Caspary L, von Bierbrauer A, Ehrly AM, Junger M, Jung F, Lawall H: Standardisierung der Nagelfalz-Kapillarmikroskopie in der Routinediagnostik. VASA. 1997, 25: 5-10.
12.
go back to reference Hoffmann U, Franzeck UK, Bollinger A: Laser-Doppler-Technik bei Krankheiten der peripheren Gefässe. Dtsch Med Wochenschr. 1992, 117: 1889-1897.CrossRefPubMed Hoffmann U, Franzeck UK, Bollinger A: Laser-Doppler-Technik bei Krankheiten der peripheren Gefässe. Dtsch Med Wochenschr. 1992, 117: 1889-1897.CrossRefPubMed
13.
go back to reference Franzeck UK, Stengele B, Panradl U, Wahl P, Tillmanns H: Cutaneous reactive hyperaemia in short-term and long-term type I diabetes – continuous monitoring by a combined laser Doppler and transcutaneous oxygen probe. VASA. 1990, 19: 8-15.PubMed Franzeck UK, Stengele B, Panradl U, Wahl P, Tillmanns H: Cutaneous reactive hyperaemia in short-term and long-term type I diabetes – continuous monitoring by a combined laser Doppler and transcutaneous oxygen probe. VASA. 1990, 19: 8-15.PubMed
14.
go back to reference Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA, Rodnan GP, Sharp GC, Wolfe JF: Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980, 23: 183-189.CrossRefPubMed Maricq HR, LeRoy EC, D'Angelo WA, Medsger TA, Rodnan GP, Sharp GC, Wolfe JF: Diagnostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum. 1980, 23: 183-189.CrossRefPubMed
15.
go back to reference Lindh H, Johansson G, Hedberg M, Henning GB, Grimby G: Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol. 1995, 24: 34-37.CrossRefPubMed Lindh H, Johansson G, Hedberg M, Henning GB, Grimby G: Muscle fiber characteristics, capillaries and enzymes in patients with fibromyalgia and controls. Scand J Rheumatol. 1995, 24: 34-37.CrossRefPubMed
16.
go back to reference Morf S, Forster A, Amann B, Franzeck UK, Michel BA, Koppensteiner R, Uebelhart D, Sprott H: Microcirculation changes in patients with fibromyalgia measured by capillary microscopy and laser doppler fluxmetry: a comparative study with healthy subjects and scleroderma patients. Ann Rheum Dis. 2002, 48- Morf S, Forster A, Amann B, Franzeck UK, Michel BA, Koppensteiner R, Uebelhart D, Sprott H: Microcirculation changes in patients with fibromyalgia measured by capillary microscopy and laser doppler fluxmetry: a comparative study with healthy subjects and scleroderma patients. Ann Rheum Dis. 2002, 48-
17.
go back to reference Morf S, Forster A, Franzeck UK, Caravatti M, Michel BA, Koppensteiner R, Uebelhart D, Sprott H: Mikrozirkulationsstörungen bei Patienten mit rheumatoider Arthritis. VASA. 2001, 6- Morf S, Forster A, Franzeck UK, Caravatti M, Michel BA, Koppensteiner R, Uebelhart D, Sprott H: Mikrozirkulationsstörungen bei Patienten mit rheumatoider Arthritis. VASA. 2001, 6-
Metadata
Title
Microcirculation abnormalities in patients with fibromyalgia – measured by capillary microscopy and laser fluxmetry
Authors
Susanne Morf
Beatrice Amann-Vesti
Adrian Forster
Ulrich K Franzeck
Renate Koppensteiner
Daniel Uebelhart
Haiko Sprott
Publication date
01-12-2004
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2005
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar1459

Other articles of this Issue 2/2005

Arthritis Research & Therapy 2/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.